Clinical Trial Update: Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating boceprevir in HIV-Hepatitis C coinfected patients who failed prior peg-interferon/ribavirin therapy; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Boceprevir (boceprevir)

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: HCV Coinfection, HIV-1 Infection | Phase 2 | Status: COMPLETED